These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 7961014)

  • 1. Dose and volume effects on fibrosis after breast conservation therapy.
    Borger JH; Kemperman H; Smitt HS; Hart A; van Dongen J; Lebesque J; Bartelink H
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1073-81. PubMed ID: 7961014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant.
    Lawenda BD; Taghian AG; Kachnic LA; Hamdi H; Smith BL; Gadd MA; Mauceri T; Powell SN
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):671-80. PubMed ID: 12788172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External beam irradiation plus (192)Ir implant after breast-preserving surgery in women with early breast cancer.
    Moreno F; Guedea F; Lopez Y; Ferrer F; Gutierrez C; Petriz L; Pera J
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):757-65. PubMed ID: 11020573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial.
    Hattangadi JA; Powell SN; MacDonald SM; Mauceri T; Ancukiewicz M; Freer P; Lawenda B; Alm El-Din MA; Gadd MA; Smith BL; Taghian AG
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):791-800. PubMed ID: 22099046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy.
    Touboul E; Belkacemi Y; Lefranc JP; Uzan S; Ozsahin M; Korbas D; Buffat L; Balosso J; Pene F; Blondon J
    Radiother Oncol; 1995 Feb; 34(2):105-13. PubMed ID: 7597208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
    Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
    Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: analysis of 289 cases.
    Deore SM; Sarin R; Dinshaw KA; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):601-6. PubMed ID: 8330988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.
    Liao Z; Strom EA; Buzdar AU; Singletary SE; Hunt K; Allen PK; McNeese MD
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1191-200. PubMed ID: 10889372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the dosimetric coverage of interstitial high-dose-rate breast implants.
    Kestin LL; Jaffray DA; Edmundson GK; Martinez AA; Wong JW; Kini VR; Chen PY; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):35-43. PubMed ID: 10656370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-irradiation of the chest wall for local breast cancer recurrence : Results of salvage brachytherapy with hyperthermia.
    Auoragh A; Strnad V; Ott OJ; Beckmann MW; Fietkau R
    Strahlenther Onkol; 2016 Sep; 192(9):617-23. PubMed ID: 27381751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late chest wall toxicity after MammoSite breast brachytherapy.
    Brashears JH; Dragun AE; Jenrette JM
    Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.
    Perez CA; Taylor ME; Halverson K; Garcia D; Kuske RR; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):995-1007. PubMed ID: 8600112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
    Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.